Sign in

CIK 0001840233

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851623397
Phone
+1 617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4/A Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Open-market buy 10% owner bought 42,469 shares at an average $9.66 ($410,161)
  8. 3 Insider Initial Statement of Ownership
  9. 4/A Open-market buy 10% owner bought 625,000 shares at $16.00 ($10,000,000)
  10. 4 Open-market buy 10% owner bought 775,000 shares at $16.00 ($12,400,000)
  11. 4 Conversion See Remark 1 acquired 218,705 shares (conversion)
  12. 4 Conversion See Remark 1 acquired 1,881,355 shares (conversion)
  13. 4 Conversion 10% owner acquired 2,602,264 shares (conversion)
  14. 4 Conversion 10% owner acquired 1,475,121 shares (conversion)
  15. 4 Open-market buy 10% owner bought 250,000 shares at $16.00 ($4,000,000)
  16. 4 Conversion 10% owner acquired 680,825 shares (conversion)
  17. 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
  18. 4 Open-market buy 10% owner bought 312,500 shares at $16.00 ($5,000,000)
  19. 4 Open-market buy 10% owner bought 187,500 shares at $16.00 ($3,000,000)
  20. 4 Derivatives Options or other derivatives

Page 6 of 8 · 150 filings